Skip to main content

Table 1 Endoscopic procedures performed between 23 March 2020 and 10 May 2020

From: Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: the care must go on

EGD

n = 184; age 60 ± 17 years; 72 females (39%); 59 out-patients (32%); 160 available rtPCR SARS-CoV-2 (87%)

Indication

 

Outcome

[normal; endoscopic therapy; changed management]

1)Emergency/essential

50 (27%)

12; 56; 74%

2)Urgent

51 (28%)

26; 24; 44%

3)Non-urgent symptomatic

59 (32%)

31; 0; 7%

4)Non-urgent asymptomatic

24 (13%)

21; 8; 0%

Colonoscopy

n = 118; age 64 ± 17 years; 49 females (42%); 37 out-patients (31%); 106 available rtPCR SARS-CoV-2 (90%)

Indication

 

Outcome

[normal; endoscopic therapy; changed management]

1)Emergency/essential:

28 (24%)

11; 36; 75%

2)Urgent:

38 (32%)

32; 21; 32%

3)Non-urgent symptomatic:

31 (26%)

39; 32; 10%

4)Non-urgent asymptomatic:

21 (18%)

57; 10; 10%

ERCP

n = 42; age 71 ± 15 years; 23 females (55%); 42 in-patients (100%); 38 available rtPCR SARS-CoV-2 (91%)

Indication

Outcome

[normal; endoscopic therapy]

1)Emergency/essential:

29 (69%)

210; 97%

2)Non-urgent asymptomatic:

13 (31%)

18; 92%

  1. Indications for endoscopies were classified on the basis of the list released by the British Society of Gastroenterology
  2. EGD esophagogastroduodenoscopy, ERCP endoscopic retrograde cholangiopancreatography